Clinical Trial Update: OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis

View source ↗

Summary

This clinical trial update describes the OverTTuRe study on characteristics, treatment patterns, and outcomes in patients with transthyretin (ATTR) amyloidosis.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloidosis

Snippet

Sponsor: AstraZeneca | Conditions: ATTR Amyloidosis | Status: RECRUITING